| Blood-based biomarkers for personalized risk assessment of breast and ovarian cancers |
Johannes Fahrmann |
University of Texas MD Anderson Cancer Center |
PLCO |
Jul 1, 2023 |
2022-0048 |
| Dietary intake of phytoestrogens and the risk of bladder cancer in the PLCO Screening Trial |
yadong Li |
The Second Affiliated Hospital of chongqing medical university |
PLCO |
Jun 22, 2023 |
PLCO-1261 |
| Characterizing the independent and joint contributions of the chemical, non-chemical, and social-structural environment on cancer incidence and mortality in the PLCO Study |
Jessica Madrigal |
Jessica Madrigal |
PLCO |
Jun 22, 2023 |
PLCO-1259 |
| Impact of treatment options on patient outcomes in hard - to - treat cancers: creating a personalized treatment framework using Machine Learning to address disparities in developed v. LMIC nations’ healthcare |
Georgia Perakis |
Massachusetts Institute of Technology |
PLCO |
Jun 22, 2023 |
PLCOI-1256 |
| In Silico Testing of Hypotheses for the Effect of Smoking on Somatic Evolution in the Healthy Human Lung |
Sam Janes |
University College London |
PLCO |
Jun 22, 2023 |
PLCO-1258 |
| Higher dietary anthocyanidins is associated with reduced risk of biliary cancer in the PLCO Cancer Screening Trial |
Ling Xiang |
Department of Clinical Nutrition, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. |
PLCO |
Jun 22, 2023 |
PLCO-1257 |
| Investigating the Correlation Between Dietary Fiber Intake and Prostate Cancer Progression and Risk Severity |
Bowen Xia |
Capital Medical University |
PLCO |
Jun 15, 2023 |
PLCO-1254 |
| Analyze the effectiveness of CA-125 to detect ovarian and non-ovarian cancer. |
Joel Sokol |
Georgia Institute of Technology |
PLCO |
Jun 13, 2023 |
PLCO-1253 |
| Detection of frameshift mutations in microsatellite instable colorectal cancer in the PLCO Cancer Screening Trial |
Robert Shoemaker |
National Cancer Institute |
PLCO |
Jun 12, 2023 |
2023-0063 |
| Environmental and Metabolic Phenotyping of the Blood Cancer Exposome |
Douglas Walker |
Emory University |
PLCO |
Jun 12, 2023 |
2023-0062 |
| Quantifying the proteome: exploratory associations with hepatocellular carcinoma |
Eleanor Watts |
Eleanor L. Watts |
PLCO |
Jun 12, 2023 |
2023-0061 |
| Characterizing the role of disruptive changes in native stromal architecture and cell composition in the etiopathogenesis and natural history of multi-state colorectal and prostate cancers |
Mustapha Abubakar |
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, USA |
PLCO |
Jun 12, 2023 |
2023-0058 |
| Validation of Pathways-Based Biomarkers for the Early Detection of Prediagnostic Pancreatic Adenocarcinoma in the Blood |
Ann Killary |
The University of Texas M. D. Anderson Cancer Center |
PLCO |
Jun 12, 2023 |
2023-0056 |
| Ceramides as drivers of metabolic dysfunction and colorectal cancer risk |
Mary Playdon |
University of Utah and Huntsman Cancer Institute |
PLCO |
Jun 12, 2023 |
2023-0050 |
| improving prognosis prediction of colorectal cancer and discover prognostic new biomarkers from whole slide images using deep learning |
binshen wei |
Harbin Medical University |
PLCO |
Jun 8, 2023 |
PLCOI-1251 |
| The mining of big data in health science of multi-disease and population characteristics |
Yike Qiu |
Chongqing University of Posts and Telecommunications |
PLCO |
Jun 6, 2023 |
PLCO-1249 |
| Competing risks model with application to lung cancer and breast cancer in PLCO |
Minjung Lee |
Kangwon National University |
PLCO |
Jun 6, 2023 |
PLCO-1248 |
| External validation of a chest radiograph-based prognostic model |
Jongmin Kim |
MEDICAL IP |
PLCO |
Jun 2, 2023 |
PLCOI-1242 |
| Performance evaluation and generalisability of an AI algorithm for lung cancer detection |
Lizzie Barclay |
Annalise-AI Pty Ltd |
PLCO |
May 30, 2023 |
PLCOI-1234 |
| Survival Curves for Hierarchical Data |
Ali Parsaee |
University of Alberta |
PLCO |
May 30, 2023 |
PLCO-1241 |
